Moderna announced that it has filed a request with the FDA for Emergency Use Authorization of its Covid-19 vaccine in teens aged 12-17; the agency’s decision could come within weeks.

Stay Connected
Forbes on Facebook:
Forbes Video on Twitter:
Forbes Video on Instagram:
More From Forbes:

Moderna Asks FDA For Emergency Approval Of Its Covid 19 Vaccine In Teens Aged 12-17 | Forbes